Perbedaan Sinergi Inti Plastindo Tbk. dan Indofarma Tbk.: Sinergi Inti Plastindo Tbk. diperdagangkan di Rp122 (kapitalisasi pasar 133,19 M, volume 24 jam 144,65 jt), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: Indofarma Tbk. jauh lebih besar — sekitar 2,9× kapitalisasi pasar Sinergi Inti Plastindo Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| ESIP | INAF | |
|---|---|---|
Kapitalisasi Pasar | 133,19 M | 390,51 M |
Volume | 144,65 jt | — |
Lot | 1,45 jt | — |
Perputaran | 18,6 M | — |
Harga Rata-rata | 128,61 | — |
Nilai Transaksi | 18,6 M | — |
Harga Ekuilibrium Indikatif | 122 | — |
Volume Ekuilibrium Indikatif | 17,25 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Sinergi Inti Plastindo Tbk (the”Company”) was established based on the notarial deed No.123 dated October 12, 2001 from Dr. Irawan Soerodjo, S.H., M.Si., Notary in Jakarta. PT Tanindo Omega Pasifik is a ultimate parent entity.
Selengkapnya di halaman ESIP →PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →